Search

Author/Creator Spahn, Jessica

1. Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study. Issue 6 (June 2020)

Authors:
Lee, Michael S; Ryoo, Baek-Yeol; Hsu, Chih-Hung; Numata, Kazushi; Stein, Stacey; Verret, Wendy; Hack, Stephen P; Spahn, Jessica; Liu, Bo; Abdullah, Heba; Wang, Yulei; He, Aiwu Ruth; Lee, Kyung-Hun
Journal:
Lancet oncology
Issue:
Volume 21:Issue 6(2020)
Page Start:
808
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models. (4th November 2015)

Authors:
Spahn, Jessica; Peng, Jing; Lorenzana, Edward; Kan, David; Hunsaker, Thomas; Segal, Ehud; Mautino, Mario; Brincks, Erik; Pirzkall, Andrea; Kelley, Sean; Mahrus, Sami; Liu, Liling; Dale, Stephanie; Quiason, Cristine; Jones, Elizabeth; Liu, Yichin; Latham, Sheerin; Salphati, Laurent; DeMent, Kevin;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models. Issue 2 (December 2015)

Authors:
Spahn, Jessica; Peng, Jing; Lorenzana, Edward; Kan, David; Hunsaker, Thomas; Segal, Ehud; Mautino, Mario; Brincks, Erik; Pirzkall, Andrea; Kelley, Sean; Mahrus, Sami; Liu, Liling; Dale, Stephanie; Quiason, Cristine; Jones, Elizabeth; Liu, Yichin; Latham, Sheerin; Salphati, Laurent; DeMent, Kevin;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗